Skip to main content

How is brolucizumab administered?

Medically reviewed by Carmen Pope, BPharm. Last updated on May 28, 2024.

Official answer

by Drugs.com
  • Brolucizumab is an injectable eye preparation that is administered directly into the vitreous humor of the eye – this is a jelly-like fluid that fills the inside of the eye.
  • It is administered by a qualified physician who will numb your eye and eyelids before the procedure.
  • Most people only feel slight pressure and little or no pain while the injection is being administered.
  • Brolucizumab is administered monthly for the first three months then 8 to 12 weekly thereafter.

Brolucizumab is an injectable eye preparation that is given to treat a particular type of age-related macular degeneration (AMD) called neovascular or wet AMD. It may also be used to treat diabetic macular edema (DME). DME is a leading cause of blindness in adults in developed countries.

Brolucizumab is administered by a qualified physician by injection directly into the vitreous humor of the eye. This is a jelly-like fluid that fills the inside of the eye.

This way of giving medicine is known as "intravitreal" which literally means "inside the eye".

Brolucizumab is initially given once a month (every 25 to 31 days) for the first three doses, then once every 8 to 12 weeks thereafter, depending on response.

Related questions

Does brolucizumab hurt when it is given?

Before giving the brolucizumab injection, your physician will anesthetize the eye and eyelids using drops, gel, or a small numbing injection so the brolucizumab injection won’t hurt.

Povidone-iodine solution is usually used to clean around the eye and then an eyelid speculum may be used to keep the eyelids open during the procedure.

While you look in a particular direction, the physician will inject the medicine through the white part of the eye with a very small needle. Although you may feel slight pressure, there is little or no pain during the procedure which takes around 10 to 15 minutes.

How does brolucizumab work?

Brolucizumab works by blocking a substance called vascular endothelial growth factor A (VEGF-A).

VEGF-A is a protein that makes blood vessels grow, leaking fluid and blood into the retina, which damages the macula. Brolucizumab binds to the 3 major forms of VEGF-A, blocking their effects and slowing the growth of blood vessels and reducing their permeability, which controls leakage and slows vision loss.

Brolucizumab belongs to the class of medicines called Vascular Endothelial Growth Factor (VEGF) Inhibitors.

References

Read next

All Eyes on Ibuprofen: What are 10 Things You Need to Know?

  1. Cheap, Effective, and Overused?
  2. High Doses of Ibuprofen Can Cause Stomach Erosions
  3. Ibuprofen Thins the Blood
  4. If You Have Asthma or Rhinitis Be Careful Taking Ibuprofen
  5. Reduced Kidney Blood Flow A Danger To Some
  6. Water Retention is Not Good For Blood Pressure
  7. Long-Term Use and High-Doses Are Risky to Heart Health
  8. Ibuprofen Has No Positive Effect on Sports Performance and May Cause Harm
  9. Ibuprofen May Be Associated With Sexual Dysfunction and Infertility
  10. Do Not Take Ibuprofen During Pregnancy, Especially In the Last Trimester
Continue reading

What’s the difference between Eylea, Eylea HD, and Avastin?

Eylea, Eylea HD, and Avastin may all be used to treat neovascular (wet) age-related macular degeneration (AMD), as injections into the eye (intravitreal injections). Both Eylea and Eylea HD are FDA-approved for this indication, but use of Avastin is off-label (not an FDA-approved indication - although it has been used for this purpose since 2005). Eylea HD is a longer acting version of Eylea. Continue reading

Xiidra vs. Restasis: Which is better for dry eye?

Xiidra (lifitegrast) and Restasis (cyclosporine) are prescription eye drops used to treat dry eye disease, but they work differently and have distinct characteristics. Continue reading

Related medical questions

Drug information

Related support groups